ALXO+173.89%12.5%
BPMC0.00%12.5%
EXEL+50.36%12.5%
HOWL-66.22%12.5%
IOVA+68.22%12.5%
LVTX0.00%12.5%
SWTX0.00%12.5%
THTX+6.60%12.5%
As of Aug 6, 2026, 4:25 AM ET
Biotech '24: Oncology Constituents
ALX Oncology Holdings Inc.ALXO | 12.5% | -2.54% | -5.42% | -12.33% | -1.03% | 69.91% | -9.00% | 222.42% | 173.89% | $258.4M |
Blueprint Medicines CorporationBPMC | 12.5% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 43.83% | 0.00% | $8.36B |
Exelixis, Inc.EXEL | 12.5% | 1.25% | 2.40% | 2.11% | 6.92% | 29.36% | 28.69% | 53.08% | 50.36% | $14.25B |
Iovance Biotherapeutics, Inc.IOVA | 12.5% | -0.46% | -13.03% | 3.58% | 6.63% | 58.97% | 12.44% | 22.60% | 68.22% | $1.94B |
LAVA Therapeutics N.V.LVTX | 12.5% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $63.1M |
SpringWorks Therapeutics, Inc.SWTX | 12.5% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.01% | 0.00% | $3.54B |
Theratechnologies Inc.THTX | 12.5% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 130.61% | 6.60% | $155.9M |
Werewolf Therapeutics, Inc.HOWL | 12.5% | -3.04% | -5.85% | 25.63% | 13.88% | -36.54% | -33.02% | -55.94% | -66.22% | $19.5M |
| Theme return | — | -0.60% | -2.74% | 3.64% | 3.66% | 20.67% | 4.97% | 71.87% | 33.11% | — |
| Average | 12.5% | -0.60% | -2.74% | 2.37% | 3.30% | 15.21% | -0.11% | 52.20% | 29.11% | $3.57B |
| Median | 12.5% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 33.22% | 3.30% | $1.10B |
| Std Dev | 0.0% | 1.35% | 4.73% | 9.88% | 4.98% | 33.00% | 16.39% | 81.48% | 66.22% | $4.84B |
| Min | 12.5% | -3.04% | -13.03% | -12.33% | -1.03% | -36.54% | -33.02% | -55.94% | -66.22% | $19.5M |
| Max | 12.5% | 1.25% | 2.40% | 25.63% | 13.88% | 69.91% | 28.69% | 222.42% | 173.89% | $14.25B |
| % Positive Tickers | 12.50% | 12.50% | 37.50% | 37.50% | 37.50% | 25.00% | 75.00% | 50.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Biotech '24: Oncology tracks 8 publicly listed stocks in this theme: ALXO, BPMC, EXEL, HOWL, IOVA, LVTX, SWTX, THTX. See the constituent table for details.